-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HS24z5SMmFMdc2wlEuIk4AYoxxMwK9q41NDntl4YPaOYwFGAo/1ICnFRan5tqj5m qFZqOEXfKdxZb0Rstb4w0Q== 0001000096-04-000371.txt : 20040804 0001000096-04-000371.hdr.sgml : 20040804 20040804165349 ACCESSION NUMBER: 0001000096-04-000371 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040730 ITEM INFORMATION: Other events ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20040804 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACCELR8 TECHNOLOGY CORP CENTRAL INDEX KEY: 0000727207 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 841072256 STATE OF INCORPORATION: CO FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31822 FILM NUMBER: 04952247 BUSINESS ADDRESS: STREET 1: 303 E 17TH AVE STREET 2: SUITE 108 CITY: DENVER STATE: CO ZIP: 80203 BUSINESS PHONE: 3038638088 MAIL ADDRESS: STREET 1: 303 E 17TH ST STREET 2: SUITE 108 CITY: DENVER STATE: CO ZIP: 80203 FORMER COMPANY: FORMER CONFORMED NAME: HYDRO SEEK INC DATE OF NAME CHANGE: 19880802 8-K 1 accelr88k.txt FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2004 ------------- Accelr8 Technology Corporation ------------------------------------------------ (Exact name of registrant as specified in charter) Colorado 0-11485 84-1072256 - ------------------------------------------------------------------------------- (State or other jurisdiction (Commission File (IRS Employer of incorporation) Number) Identification No.) 303 East Seventeenth Avenue, #108, Denver, Colorado 80203 --------------------------------------------------------- (Address of principal executive offices) Registrant's telephone number, including area code: (303) 863-8088 -------------- Not Applicable. --------------- (Former name or former address, if changed since last report.) ITEM 5. COMPLETION OF SALE OF SOFTWARE BUSINESS On August 3, 2004, Accelr8 Technology Corporation announced that it had completed the sale of its software business, which consists of tools for legacy-code modernization and the resale of third-party software. A copy of the Press Release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. ITEM 7. EXHIBITS Designation Description - ----------- ----------- 99.1 Press Release dated August 3, 2004 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ACCELR8 TECHNOLOGY CORPORATION Date: August 3, 2004 By: /s/ Thomas V. Geimer --------------------------------- Thomas V. Geimer, Chairman and Chief Executive Officer EX-99.1 2 accelr88kexh991.txt PRESS RELEASE Exhibit 99.1 Contacts -------- Accelr8 Technology Corporation [GRAPHIC OMITTED Thomas V. Geimer, 303-863-8088 COMPANY LOGO] Silverman Heller Associates Phillip Bourdillon/Gene Heller, 310-208-2550 ACCELR8 TECHNOLOGY CORPORATION COMPLETES SALE OF SOFTWARE BUSINESS DENVER-August 3, 2004-Accelr8 Technology Corporation (Amex: AXK) has completed the sale of its software business, which consists of tools for legacy-code modernization and the resale of third-party software. According to Thomas Geimer, Accelr8's chairman and chief executive officer, the transaction, valued at approximately $700,000, will enable the Company to concentrate its resources on advancing the biosciences side of its business, notably the development of the BACcelr8r(TM), a rapid-response microbial diagnostic platform intended initially for use in the identification of bacterial infections in critically ill patients. Approximately $200,000 of the sales price, consisting of the assumption of support obligations under pre-existing support and maintenance agreements, will be recognized as revenue in Accelr8's fiscal fourth quarter ended July 31, 2004. About Accelr8 Technology: - ------------------------- Accelr8 Technology Corporation (www.accelr8.com) is a developer of innovative materials and instrumentation for advanced bio-analytical applications in basic research, drug discovery, molecular diagnostics, and pathogen detection for bio-defense and food safety. The company sells OptArray(TM) microarraying slides and OptiPlate(TM) multiplexed arrayable microtiter plates. It is also developing advanced detection instrumentation based on its QuanDx(TM) and YoDx(TM) array processing and detection technologies. Safe-harbor Statement: - ---------------------- Certain statements in this news release, including but not limited to statements regarding the anticipated sale of the Company's software business, may be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements regarding future prospects and developments are based upon current expectations and involve certain risks and uncertainties that could cause actual results and developments to differ materially from the forward-looking statement, including those detailed in the company's filings with the Securities and Exchange Commission. Accelr8 Technology Corporation disclaims any intent or obligation to update these forward-looking statements. # # # -----END PRIVACY-ENHANCED MESSAGE-----